Furthermore, researchers have engineered an AAV vector targeting the brain endothelium; it alters glioma vasculature through the expression of LIGHT protein and enhances T cell infiltration into tumor cells, providing a novel perspective for glioma treatment [135]. The gene discussed is TNFSF14; the disease is glioma.